SCHEMBL6754206

SCHEMBL6754206

COCCOCCn1c(C(=O)O)cc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
CYP1A2 P05177 1/20 0.59
POLB P06746 1/20 0.59
MCL1 Q07820 4/20 0.55
CCR2 P41597 4/20 0.55
CNR2 P34972 3/20 0.47
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47
DAO P14920 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46
PKM P14618 1/20 0.46
NFKB1 P19838 1/20 0.46
RAB9A P51151 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
HDAC3 O15379 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894118 0.92 ALDH1A1 (0.64) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL29750342 0.92 ALDH1A1 (0.64) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL1422338 0.88 MCL1 (0.62) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL6752406 0.86 ALDH1A1 (0.58) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL2933072 0.86 MCL1 (0.67) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL6754262 0.85 KDM4E (0.63) CNR2MTNR1AMTNR1BSMN1; SMN2KDM4E
SCHEMBL6750557 0.83 ALDH1A1 (0.52) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL13701158 0.81 CCR2 (0.69) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL26581647 0.81 CCR2 (0.42) ALDH1A1CYP1A2POLBMCL1CCR2
SCHEMBL20609049 0.80 HDAC3 (0.53) ALDH1A1CYP1A2POLBMCL1CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US claimed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US claimed
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US disclosed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077646-A1 Indole nitriles TPH1, IDO1, NAT1 ALDH1A1 535/4885CYP1A2 183/4885POLB 3574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.